AGP Wire

AGP

A 2026 supplier guide ranks five Chinese storage rack makers for Middle East buyers based on scale, certifications, engineering support, and export history across GCC and MENA markets.

AGP

The acute migraine treatment market is projected to grow from $2.9 billion in 2025 to $3.22 billion in 2026, driven by higher migraine prevalence, wider use of triptans and NSAIDs, and expanding pharmacy access.

AGP

The 3D cell culture technologies market is projected to grow from $3.96 billion in 2025 to $9.8 billion by 2030, driven by drug discovery, regenerative medicine and organ transplantation demand.

AGP

The Business Research Company projects the 3D hydrogel culture market will grow from $2.24 billion in 2025 to $4.91 billion by 2030, driven by cancer research, drug testing and regenerative medicine.

AGP

The Business Research Company says the Aplisol market is set to grow through 2026 as tuberculosis screening, public health programs and healthcare spending increase.

AGP

The Business Research Company says the Actimmune market is set for continued growth through 2026 to 2035, led by rising diagnosis of rare immune disorders, broader specialty care access and favorable reimbursement.

AGP

The Business Research Company projects the global Addison’s disease market will grow from $2.46 billion in 2026 to $3.53 billion by 2030. The report points to rising autoimmune disease rates, broader diagnostic access and newer treatment…

AGP

The Business Research Company says the Amphadase market is expanding as minimally invasive procedures, ophthalmic care and skin-disorder treatments gain traction.

AGP

The Business Research Company says the global Alphanine market is poised for expansion through 2035, driven by rising hemophilia prevalence, greater awareness of rare diseases and wider use of prophylactic care.

AGP

The Business Research Company says the global Alyglo market, centered on IVIG therapy for primary humoral immunodeficiency, is set to expand through 2030 as immune disorder diagnoses rise and home infusion use grows.

AGP

The Business Research Company says the global Acthrel market is expanding on stronger demand for endocrine diagnostics, higher healthcare spending and rising endocrine disease prevalence.

AGP

The addictions therapeutics market is projected to grow from $7.46 billion in 2025 to $7.93 billion in 2026, with North America holding the largest regional share.

AGP

The Business Research Company says the Alferon N Injection market is set to expand through 2035 as hepatitis cases, HPV-related demand and higher healthcare spending support use of interferon-based treatments.

AGP

The Business Research Company says the Apidra market is gaining traction as diabetes cases climb, healthcare spending rises and personalized medicine expands.

AGP

The Business Research Company says the Ambirix vaccine market is set for steady expansion through 2035, driven by hepatitis cases, wider pediatric vaccination efforts, and higher healthcare spending.

AGP

The Business Research Company says the Amondys 45 market is set to grow through 2035 as genetic testing, personalized medicine and rare-disease treatment adoption accelerate.

AGP

The Business Research Company says the Asceniv market is expanding as demand rises for immunoglobulin therapies used in primary immunodeficiency and respiratory disease care.

AGP

The global Actemra (tocilizumab) market is projected to grow from $5.71 million in 2025 to $6.32 million in 2026, then reach $9.34 million by 2030, according to The Business Research Company.

AGP

The global market for adrenogenital syndrome treatments is projected to grow from $13.56 billion in 2026 to $16.95 billion by 2030, driven by personalized medicine, genetic testing and broader access to care.

AGP

The Business Research Company says the AlphaNine HP market is gaining momentum as hemophilia B treatment advances and demand rises for safer plasma-derived products.